Wall Street is positive on F-Star Therapeutics Inc (FSTX). On average, analysts give the stock a Hold rating. The average price target is $7, which means analysts expect the stock to rise by 42.57% over the next twelve months. That average ranking earns the stock an Analyst Rating of 6, which is better than 6% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating FSTX a Hold today. Find out what this means to you and get the rest of the rankings on FSTX!